Determinants of doxapram utilization: A survey of practice in the French Neonatal and Intensive Care Units;Enquête sur l'utilisation du doxapram dans les unités de néonatologie en France

Archives de Pediatrie

Volumn 12, Issue 2, 2005, Pages 151-155

  Benard M ^a   Boutroy, M J ^b   Glorieux, I ^a   Casper, C ^a  

^a HÔPITAL DES ENFANTS   (France)

^b Maternite Regionale Universitaire   (France)

Author keywords

Apnea; Doxapram; Infant; Premature infant

Indexed keywords

DOXAPRAM; METHYLXANTHINE;

APNEA; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG UTILIZATION; FRANCE; HOSPITAL DEPARTMENT; HUMAN; INTENSIVE CARE UNIT; NEWBORN INTENSIVE CARE; QUESTIONNAIRE; REVIEW; SIDE EFFECT;

EID: 13844275685     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2004.10.024     Document Type: Article

References (39)

1. R.A. Mitchell, and D.A. Herbert Potencies of doxapram and hypoxia in stimulating carotid-body chemoreceptors and ventilation in anesthetized cats Anesthesiology 42 1975 559 566
2. K. Hirsh, and S.C. Wang Selective respiratory stimulating action of doxapram compared to pentylenetetrazol J. Pharmacol. Exp. Ther. 189 1974 1 11
3. L. Lareng, C. Vaysse, and B. Cathala Use of doxapram hydrochloride in the treatment of drug induced toxic comas Cah. Anaesthesiol. 19 1971 1959 1972
4. E.D. Burnard, R.G. Moore, and H. Nichol A trial of doxapram in the recurrent apnea of prematurity L. Stern W. Oh B. Frïs-Hansen Intensive care in the newborn II 1978 Masson Press New York 143 148
5. K.J. Barrington, N.N. Finer, G. Torok-Both, F. Jamali, and R.T. Coutts Dose-response relationship of the doxapram in the therapy for refractory idiopathic apnea of prematurity Pediatrics 80 1987 22 27
6. K.J. Barrington, and S.C. Muttitt Randomized, controlled, blinded trial of doxapram for extubation of the very low birthweight infant Acta Paediatr. 87 1998 191 194
7. D.J. Henderson-Smart, and P.G. Davis Prophylactic doxapram for the prevention of morbidity and mortality in preterm infants undergoing endotracheal extubation Cochrane Database Syst. Rev. 2000 CD001966
8. F. Eyal, G. Alpan, E. Sagi, B. Glick, O. Peleg, and Y. Dgani Aminophyllin versus doxapram in idiopathic apnea of prematurity: a double-blind controlled study Pediatrics 75 1985 709 713
9. A. Peliowski, and N.N. Finer A blinded, randomized, placebo-controlled trial to compare theophylline to doxapram for the treatment of apnea of prematurity J. Pediatr. 116 1990 648 653
10. M.G. Romeo, N. Proto, L.G. Tina, M.G. Parisi, and G. Distefano A comparison of the efficacy of aminophylline and doxapram in preventing idiopathic apnea in preterm newborn infants Pediatr. Med. Chir. 13 1991 77 81
11. L.P. Brion, C. Vega-Rich, G. Reinersman, and P. Roth Low dose doxapram for apnea unresponsive to aminophylline in very low birthweight infants J. Perinatol. 11 1991 359 364
12. C. Huon, E. Rey, P. Mussat, S. Parat, and G. Moriette Low-dose doxapram for treatment of apnoea following early weaning in very low birth weight infants: a randomized, double-blind study Acta Paediatr. 87 1998 1180 1184
13. D.J. Henderson-Smart, and P.A. Steer Doxapram treatment for apnea in preterm infants Cochrane Database Syst. Rev. 2001 CD000074
14. J. Tay-Uyboco, K. Kwiatkowski, D.B. Cates, B. Seifert, S.U. Hasan, and H. Rigatto Clinical and physiological responses to prolonged nasogastric administration of doxapram for apnea of prematurity Biol. Neonate 59 1991 190 200
15. A. Bairam, L. Akramoff-Gershan, K. Beharry, N. Laudignon, A. Papageorgiou, and J.V. Aranda Gastrointestinal absorption of doxapram in neonates Am. J. Perinatol. 8 1991 110 113
16. F. Jamali, K.J. Barrington, N.N. Finer, R.T. Coutts, and G.A. Torok-Both Doxapram dosage regimen in apnea of prematurity based on pharmacokinetic data Dev. Pharmacol. Ther. 11 1988 253 257
17. Caturla L. Pharmacocinétique de population du doxapram chez le nouveau-né [thèse]. Toulouse : université Paul Sabatier ; 2003.
18. A. Bairam, P.W. Blanchard, K. Mullahoo, K. Beharry, N. Laudignon, and J.V. Aranda Pharmacodynamic effects and pharmacokinetic profiles of keto-doxapram and doxapram in newborn lambs Pediatr. Res. 28 1990 142 146
19. R.T. Coutts, F. Jamali, F. Malek, A. Peliowski, and N.N. Finer Urinary metabolites of doxapram in premature neonates Xenobiotica 21 1991 1407 1418
20. A. Bairam, M. Faulon, P. Monin, and P. Vert Doxapram for initial treatment of idiopathic apnea of prematurity Biol. Neonate 61 1992 209 213
21. T. Yamazaki, M. Kajiwara, K. Itahashi, and M. Fujimura Low-dose doxapram therapy for idiopathic apnea of prematurity Pediatr. Int. 43 2001 124 127
22. H. Kumita, S. Mizuno, M. Shinohara, T. Ichikawa, and T. Yamazaki Low-dose doxapram therapy in premature infants and its CSF and serum concentrations Acta Paediatr. Scand. 80 1991 786 791
23. F. Barb́, C. Hansen, Y. Badonnel, H. Legagneur, P. Vert, and M.J. Boutroy Severe side effects and drug plasma concentrations in preterm infants treated with doxapram Ther. Drug Monit. 21 1999 547 552
24. J.P. Cloherty, and A.R. Stark Manual of Neonatal Care 1998 Lippincott-Raven Philadelphia
25. S.M. Donn 3rd edition. Michigan Manual of Neonatal Intensive Care 2003 Hanley and Belfus Philadelphia
26. J.M. Rennie, and N.R.C. Roberton 4th edition. A Manual of Neonatal Intensive Care 2002 Arnold New York
27. Klaus, and Faranoff fifth edition. Care of the high-Risk Neonate 2001 Saunders Philadelphia
28. G.S. De Villiers, A. Walele, P.L. Van der Merwe, and N.N. Kalis Second degree atrioventricular heart block after doxapram administration J. Pediatr. 133 1998 149 150
29. G.D. Jordan, N.J. Themelis, S.O. Messerly, R.V. Jarrett, J. Garcia, and C.G. Frank Doxapram and potential benzyl alcohol toxicity: a moratorium on clinical investigation? Pediatrics 78 1986 540 541
30. M.G. Romeo, P. Betta, L.G. Tina, S. Cilauro, A. Saporito, and G. Distefano Oral administration of doxapram in preterm neonates with aminophylline-resistant idopathic apnea crisis Pediatr. Med. Chir. 17 1995 123 126
31. D.J. Henderson-Smart, and P. Steer Doxapram versus methylxanthine for apnea in preterm infants Cochrane Database Syst. Rev. 2000 CD000075
32. C.F. Poets, S. Darraj, and B. Bohnhorst Effect of doxapram on episodes of apnea, bradycardia and hypoxaemia in preterm infants Biol. Neonate 76 1999 207 213
33. J.M. Hascoët, and M.J. Boutroy Traitement des apńes du pŕmatuŕ Arch. Pediatr. 5 1998 546 552
34. A. Bairam, and P. Vert Low-dose doxapram for apnoea of prematurity Lancet 1 1986 793 794
35. C. Maillard, M.J. Boutroy, J. Fresson, F. Barb́, and J.M. Hascoët QT interval lengthening in premature infants treated with doxapram Clin. Pharmacol. Ther. 70 2001 540 545
36. C. Sreenan, P.C. Etches, N. Demianczuk, and C.M. Robertson Isolated mental developmental delay in very low birth weight infants: association with prolonged doxapram therapy of apnea J. Pediatr. 139 2001 832 837
37. J.M. Hascoet, I. Hamon, and M.J. Boutroy Risks and benefits of therapies for apnoea in premature infants Drug Saf. 23 2000 363 379
38. A. Bairam, M.J. Boutroy, and P. Vert Un stimulant respiratoire, le doxapram, et ses applications en ṕdiatrie Arch. Fr. Pediatr. 49 1992 469 474
39. D. Millar, and B. Schmidt Controversies surrounding xanthine therapy Semin. Neonatol. 9 2004 239 244